PPA
RDUS

Parametric Portfolio Associates’s Radius Health, Inc. RDUS Stock Holding History

Parametric Portfolio Associates’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$193K Sell
21,819
-7,854
-26% -$59.5K ﹤0.01% 3453
2021
Q4 		$205K Buy
29,673
+2,462
+9% +$36.1K ﹤0.01% 3415
2021
Q3 		$338K Sell
27,211
-54,025
-67% -$779K ﹤0.01% 3253
2021
Q2 		$1.48M Sell
81,236
-9,270
-10% -$184K ﹤0.01% 2594
2021
Q1 		$1.89M Buy
90,506
+10,051
+12% +$212K ﹤0.01% 2816
2020
Q4 		$1.44M Buy
+80,455
New +$1.21M ﹤0.01% 2856
2020
Q2 		– Sell
-29,693
Closed -$386K – 4037
2020
Q1 		$386K Sell
29,693
-12,170
-29% -$217K ﹤0.01% 3303
2019
Q4 		$844K Sell
41,863
-70,217
-63% -$1.71M ﹤0.01% 3142
2019
Q3 		$2.89M Buy
112,080
+4,673
+4% +$115K ﹤0.01% 2427
2019
Q2 		$2.62M Buy
107,407
+74,680
+228% +$1.63M ﹤0.01% 2483
2019
Q1 		$653K Buy
32,727
+5,125
+19% +$93.5K ﹤0.01% 3215
2018
Q4 		$455K Buy
27,602
+11,596
+72% +$195K ﹤0.01% 3355
2018
Q3 		$285K Sell
16,006
-1,229
-7% -$27.8K ﹤0.01% 3629
2018
Q2 		$508K Sell
17,235
-2,857
-14% -$90.3K ﹤0.01% 3340
2018
Q1 		$722K Buy
20,092
+3,103
+18% +$112K ﹤0.01% 3175
2017
Q4 		$540K Buy
16,989
+9,262
+120% +$291K ﹤0.01% 3290
2017
Q3 		$298K Sell
7,727
-9,622
-55% -$378K ﹤0.01% 3677
2017
Q2 		$785K Sell
17,349
-18,157
-51% -$694K ﹤0.01% 3113
2017
Q1 		$1.37M Sell
35,506
-2,316
-6% -$97.2K ﹤0.01% 2698
2016
Q4 		$1.44M Buy
37,822
+115
+0.3% +$5.47K ﹤0.01% 2607
2016
Q3 		$2.04M Buy
37,707
+12,216
+48% +$621K ﹤0.01% 2321
2016
Q2 		$937K Buy
25,491
+787
+3% +$27.8K ﹤0.01% 2873
2016
Q1 		$777K Buy
24,704
+20,142
+442% +$697K ﹤0.01% 3084
2015
Q4 		$281K Buy
+4,562
New +$288K ﹤0.01% 3592

Other funds holding RDUS

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RP
Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Parametric Portfolio Associates's RDUS Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Radius Health, Inc. (RDUS) stake by 26% in Q1 2022, selling an estimated $59.5K and leaving 21,819 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #3453.

Parametric Portfolio Associates first reported a position in RDUS in Q4 2015 and has held it in 24 quarters since. The position peaked at $2.89M in Q3 2019. 138 funds tracked by Wall St. Rank hold RDUS as of Q1 2022.

  • Parametric Portfolio Associates held 21,819 shares of Radius Health, Inc. worth $193K as of Q1 2022.
  • Parametric Portfolio Associates sold 7,854 Radius Health, Inc. shares in Q1 2022, an estimated $59.5K.
  • Radius Health, Inc. made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3453 holding.
  • Parametric Portfolio Associates first reported a position in Radius Health, Inc. in Q4 2015 and has held it in 24 quarters since.
  • Parametric Portfolio Associates's Radius Health, Inc. position peaked at $2.89M in Q3 2019.
  • 138 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.